Centrient Pharmaceuticals is the leading manufacturer of beta-lactam antibiotics, and a provider of next generation statins and anti-fungals. Founded 150 years ago as the ‘Nederlandsche Gist- en Spiritusfabriek’, the company was known as Gist Brocades and more recently DSM Sinochem Pharmaceuticals. Headquartered in Rotterdam (Netherlands), Centrient Pharmaceuticals has production facilities and sales offices in China, India, the Netherlands, Spain, Egypt, the United States and Mexico. Centrient Pharmaceuticals is wholly owned by Bain Capital Private Equity, a leading global private investment firm.
We combine our unique skills in fermentation and bio-catalysis to provide the highest quality products based on our fully vertically integrated global manufacturing and distribution capabilities. Our quality standards and our unique technology platform allow us to provide the world with high quality life-saving medicines in a sustainable, responsible and reliable way.
Think global, act local
We are the leading supplier and producer of green beta-lactams antibiotics worldwide and the only FDA approved penicillin producer in the western world. Centrient Pharmaceuticals has a strong track record in regulated markets and a clear focus on growing our presence in Asia and Latin America. Each of our four business units has a defined regional focus, meaning we give our customers the best of both worlds: access to the knowledge and resources of a global leader with local support you can rely on. Helping you stay competitive in this fast-paced environment, we provide regulatory, technical and after sales support – making Centrient Pharmaceuticals the partner of choice for your generic pharmaceutical solutions.